Antagonism by dibutyryl adenosine cyclic 3',5'-monophosphate and testosterone of cell rounding reactions.
In an attempt to understand further the mechanism of the morphological and functional "reverse transformation" of CHO-K1 cells induced by dibutyryl adenosine cyclic 3',5'-monophosphate (cAMP) and testosterone, the kinetics of variation in the susceptibility of cells to rounding after the addition or deletion of dibutyryl cAMP and testosterone have been investigated. Changes in susceptibility to cell rounding upon removal of divalent cations or pulse exposure to concanavalin A were complete within 0.5-1 h after addition or deletion of drug. In comparison, the gross conversion of CHO-K1 cells from epithelial- to fibroblast-like morphology after drug treatment or the converse change after drug removal required 8 or 4 h, respectively. The effects on cell rounding are not caused by an effect of dibutyryl cAMP upon cell growth rate. Inhibitor experiments indicate that the changes investigated do not require continued RNA or protein synthesis and are not prevented by agents which depolymerize microtubules.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002118:Calcium / Q000494:pharmacology; D002460:Cell Line / Q000502:physiology*; D002999:Clone Cells; D003208:Concanavalin A / Q000494:pharmacology; D006224:Cricetinae; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003703:Demecolcine / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D010053:Ovary; D011691:Puromycin / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology*; D013997:Time Factors
D003208:Concanavalin A; D003609:Dactinomycin; D013739:Testosterone; D011691:Puromycin; D003994:Bucladesine; D003513:Cycloheximide; D008274:Magnesium; D002118:Calcium; D003703:Demecolcine